To validate expression levels of the CCNB1/CDC42/MAPK7/CD44 gene signatures in GBM, we explored the HPA database for IHC to compare gene expression levels between GBM tumor tissues and normal samples. This evidence concerns the gene CD44 and glioblastoma.